Publication Month: Sep 2021 | Report Code: TIPRE00022440 | No. of Pages: 234 | Category: Medical Device | Status: Published
Get more information on this report :
Chronic diseases such as heart disease, diabetes, stroke, and obesity are the leading causes of death across the world and these diseases account for the largest share of the country's health care cost. According to CDC, in 2018, ~9% of the total population had diabetes, and it is the major cause of lower-limb amputation and kidney failure in the US. Further, the report also suggests that more than 1.5 million American population are diagnosed with diabetes in the US every year. Similar scenario of higher prevalence of diabetes persists in other regions such as Europe, Asia Pacific, and Middle East and Africa. According to International Diabetes Federation's published IDF Diabetes Atlas, in 2017, south-east part of Asia had ~19% of the total diabetes population globally.
According to the American College of Cardiology Foundation, in 2018, CHD was the major cause of death, owing to cardiovascular disease (CVD), followed by stroke, high BP, heart failure, and other CVDs contribution share of 16.8%, 9.4%, 9.0%, and 17.9% respectively. By 2035, nearly 130 million adults in the US are feared to have CVD. Thus, rising geriatric population and related chronic disorders are expected to push the sales of remote patient monitoring devices, thus propelling the growth of global remote patient monitoring devices market during the forecast period.
The rate of obesity among population is growing rapidly in developed as well as developing countries across the world. Unhealthy lifestyle and sedentary life are the factors driving the number of obese individuals. According to the Organization for Economic Co-operation, (OECD), in 2020, more than 1.9 billion adults of 18 years and above were overweight, of these over 650 million were obese. The number has grown rapidly in Canada, Australia, Chile, the UK, and South Africa. Obese population is expected to be high in the US, Mexico, and England, consisting of around 47%, 39% and 35% respectively by next 2 decades.
Diabetes is caused by the body’s inability to secret insulin and is considered a life-threatening disorder with no ensured cure. This inability prevents body from adequately regulating blood glucose levels. Diabetes is one of the largest diseases of the 21st century. According to the International Diabetes Federation (IDF), in 2017, the total number of diabetic populations in North America was 46 million and by 2045, it is expected to rise to 62 million. The increase in number of people suffering from various lifestyle and chronic diseases creates a need for efficient devices and solutions to monitor individual’s physiological parameters, under a physician’s consultation, thereby increasing the demand for remote patient monitoring devices. This is likely to promote the market growth during the forecast years.
The global remote patient monitoring market, based on type, is segmented into software, devices, and services. In 2021, the devices segment accounted for the largest share in the market and is expected to retain its dominance during the forecast years. The market growth for this segment is attributed to the high-volume demand for vital sign remote patient monitoring devices across various countries worldwide. In addition, the surge in demand for respiratory and multifunctional monitoring devices due to the COVID-19 outbreak also contributes to the market growth for this segment. Furthermore, medical device manufacturers are constantly focusing on the improvement of the quality and innovations in these devices, which would help the segment to hold a dominant share in the remote patient monitoring market during the forecast years.
Get more information on this report :
By end-user, the remote patient monitoring market is segmented into providers, payers, patients, and others. The providers segment held the largest share of the market in 2021, whereas the patient segment is estimated to register the highest CAGR in the market during the forecast period.
|Market Size Value in||US$ 29,062.30 Million in 2020|
|Market Size Value by||US$ 188,952.22 Million by 2028|
|Growth rate||CAGR of 30.7% from 2021-2028|
|No. of Pages||234|
|No. of Tables||144|
|No. of Charts & Figures||81|
|Historical data available||Yes|
|Segments covered||Type, End User, and Geography|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
The key market players, such as Koninklijke Philips N.V., NIHON KOHDEN CORPORATION, Medtronic, General Electric, Cerner Corporation, Siemens Healthineers AG, Boston Scientific Corporation, Omron Healthcare, Abbott, and VitalConnect, adopt several organic and inorganic strategies to enhance their revenue and market standings. For instance, in May 2021, Medtronic introduced a new pediatric monitor that alerts doctors about potential airway obstructions during ventilation. Furthermore, in June 2020, Koninklijke Philips N.V. launched the Avalon CL Fetal and Maternal Pod and Patch in the US, Europe, Australia, New Zealand, and Singapore for remote monitoring.
The List of Companies - Remote Patient Monitoring Market